News

Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process

  • NanoString announced Wednesday that it will be acquired by Bruker, ending the company's restructuring process that included a Chapter 11 bankruptcy plan.
    04/17/2024

NanoString Products Drive Breakthrough Cancer Research at the 2024 American Association of Cancer Research (AACR) Conference

  • SEATTLE--(BUSINESS WIRE)-- #AACR24--NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, will present at the 2024 meeting of the American Association of Cancer Research studies delving into metastatic brain tumors, triple-negative breast cancer, pancreatic cancer and dozens of other vital research areas. The conference will be held in San Diego, April 5-10, 2024. NanoString and its customers will showcase 110 posters and highlight its products.
    04/04/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

NanoString Technologies, Inc. (NSTG) can hold. Click on Rating Page for detail.

The price of NanoString Technologies, Inc. (NSTG) is 0.1053 and it was updated on 2024-05-26 07:01:22.

Currently NanoString Technologies, Inc. (NSTG) is in undervalued.

News
    
News

Why Is NanoString (NSTG) Stock Up 115% Today?

  • Life science applications specialist NanoString (NASDAQ: NSTG ), which provides tools for discovery and translation research, announced that it has entered into a credit agreement with its existing lenders. Driving the need for such an arrangement was a bankruptcy filing at the beginning of the week.
    Fri, Feb. 09, 2024

NanoString Announces Completion of Financing to Support Restructuring Process

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into a credit agreement with its existing lenders comprised of (a) $12,500,000 in new money term loans which have already been approved for funding pursuant to the February 5 interim order of the U.S. Bankruptcy court approving the credit facility, and (b) an additional $35,000,000 in new money term loa.
    Fri, Feb. 09, 2024

Why Is NanoString (NSTG) Stock Up 180% Today?

  • Investors looking at today's price action in NanoString (NASDAQ: NSTG ) stock ought to be shaking their heads in amazement. Indeed, after announcing the company would be filing for bankruptcy protection on Monday, many thought the story with NanoString was over.
    Thu, Feb. 08, 2024

Why Is NanoString Technologies (NSTG) Stock Down 59% Today?

  • NanoString Technologies (NASDAQ: NSTG ) stock is taking a beating on Monday after the company announced a voluntary Chapter 11 bankruptcy filing. NanoString Technologies notes that this bankruptcy filing is the result of its lost litigation battles against 10x Genomics.
    Mon, Feb. 05, 2024

NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG) (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that steps are being taken to protect its business, customers, employees and its mission to “Map the Universe of Biology.” With support from key creditors, NanoString and certain of its subsidiaries have voluntarily initiated a chapter 11 restructuring proceeding in the United States Bankruptcy.
    Sun, Feb. 04, 2024
SEC Filings
SEC Filings
Press Releases
StockPrice Release
More Headlines
News

NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability

  • SEATTLE--(BUSINESS WIRE)-- #AGBT2024--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the CosMx™ Human 6K Discovery Panel, the industry's first single-cell spatial panel enabling research scientists to measure over 6,000 RNA targets, representing nearly every human biological pathway. Building on this breakthrough product developed for the CosMx Spatial Molecular Imager (SMI), Nan.
  • 02/01/2024

NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager (SMI). The data will be highlighted at the 42nd annual J.P. Morgan Healthcare Conference 2024 in San Francisco during NanoString's corporate presentation on Wednesday, January 10, 20.
  • 01/07/2024

NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq

  • Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions, or 9% of its workforce.
  • 01/06/2024

NanoString Reports Inducement Grants Under Nasdaq Listing Rules

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on December 6, 2023, the Compensation and Human Capital Committee of NanoString's Board of Directors approved the grant of, in the aggregate, 34,925 restricted stock units, or RSUs, as mat.
  • 01/05/2024

NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 42nd annual J.P. Morgan healthcare conference, being held January 8-11, 2024. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, January 10, at 5:15pm ET. Interested parties can access the live webcast from the investor.
  • 01/04/2024

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

  • Playing in the field of nano-cap stocks is similar to the concept of stealing bases. In a tight baseball game, every advantage counts.
  • 12/25/2023

NanoString Comments on Delaware District Court Verdict

  • SEATTLE--(BUSINESS WIRE)--NanoString Comments on Delaware District Court Verdict.
  • 11/19/2023

10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

  • Jury Awards 10x Genomics Over $31 Million in Damages and Finds All Seven Asserted Patents Valid and Willfully Infringed by NanoString GeoMx Decision is Third Ruling Against NanoString, Showing Serial Infringement of 10x Patents PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the District of Delaware has reached a unanimous verdict in favor of 10x Genomics in the patent infringement suit 10x filed against the GeoMx products sold by NanoString Technologies, Inc. (Nasdaq: NSTG).
  • 11/17/2023

NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience

  • SEATTLE--(BUSINESS WIRE)--NanoString will present at the Society for Neuroscience meeting new brain research powered by its spatial profiling and spatial imaging platforms.
  • 11/09/2023

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at November conferences.
  • 11/09/2023

NanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Call Transcript

  • NanoString Technologies, Inc. (NASDAQ:NSTG ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Doug Farrell - IR Brad Gray - President and CEO Tom Bailey - CFO Conference Call Participants Marta Nazarovets - JPMorgan Kyle Boucher - TD Cowen Catherine Schulte - Baird Evan Stampler - Stifel Alexander Vukasin - Canaccord Genuity Operator Good afternoon. My name is Krista and I'll be your conference operator today.
  • 11/06/2023

NanoString (NSTG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

  • While the top- and bottom-line numbers for NanoString (NSTG) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
  • 11/06/2023

NanoString Technologies Releases Operating Results for Third Quarter of 2023

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString reports Q3 2023 Operating Results.
  • 11/06/2023

Short squeeze alert for October 18th: 2 stocks that could soar

  • In stock trading, shorting is seen as a high-risk, high-reward strategy. This approach involves borrowing stocks, selling them, and betting on their price dropping to make a profit.
  • 10/18/2023

NanoString (NSTG) Grows in Translational Research With CRO Deals

  • According to NanoString (NSTG), SMI's unique ability to interrogate both RNA and proteins at ultra-high plex with subcellular resolution has made it a one-of-a-kind tool.
  • 09/12/2023

NanoString (NSTG) Advances in Xenotransplantation With New Study

  • NanoString's (NSTG) nCounter Analysis System facilitates bulk tissue transcriptome profiling, revealing the intricacies of the immune response through the nCounter Human Organ Transplant Panel.
  • 08/23/2023

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. 43rd Annual Canaccord Global Growth Conference Wednesday, August 9th Tom Bailey, NanoString's chief financial officer, and Doug Farrell, VP of Investor Relations, will participate in a fireside discussion hosted by Canaccord.
  • 08/08/2023

NanoString Technologies, Inc. (NSTG) Q2 2023 Earnings Call Transcript

  • NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Doug Farrell - Vice President, Investor Relations & Corporate Communications Brad Gray - President & Chief Executive Officer Tom Bailey - Chief Financial Officer Conference Call Participants John Sourbeer - UBS Tom Peterson - Baird Operator Thank you for standing by. My name is Ian, and I will be your conference operator today.
  • 08/03/2023

Helen of Troy and NanoString Technologies Trade Set-ups

  • The action is hot in Helen Of Troy NASDAQ: HELE and NanoString Technologies NASDAQ: NSTG. These unrelated companies issued better-than-expected results and guidance that have their shares up double-digits in early trading.
  • 07/10/2023

Red-Hot Quality Opportunities in Genomics

  • The health care sector is currently undergoing a remarkable transformation. The recent focus on genomics has empowered medical professionals to diagnose patients more objectively and adopt proactive measures to maintain the well-being of larger populations.
  • 06/22/2023

NanoString to Webcast Presentation from Jefferies Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Jefferies Healthcare Conference, which will be held June 7-9, 2023. Brad Gray, president and chief executive officer, is scheduled to present on Thursday, June 8, 2023, at 8:30am ET. Interested parties can access the live webcast from the investor section o.
  • 05/31/2023

NanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will host a conference call on Monday, May 22, 2023, at 4:30pm ET to provide an update on the recent Decision of the Regional Court of Munich. Investors and other interested parties should register for the conference call in advance by visiting https://www.netroadshow.com/events/login?show=9b96aaa1&confId=5.
  • 05/22/2023

Why Shares of NanoString Technologies Are Falling Thursday

  • NanoString Technologies may have to stop selling certain instruments and reagents in Germany. The company said it plans to appeal the ruling.
  • 05/18/2023

NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates

  • NanoString Technologies (NSTG) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.86 per share a year ago.
  • 05/03/2023

NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023

  • SEATTLE--(BUSINESS WIRE)--NanoString to report Q1 2023 operating results on May 3, 2023.
  • 04/10/2023

NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, “AI-Driven Disruptions To Genomics & Computational Drug Discovery”, from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
  • 03/01/2023

NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -55.74% and 3.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 02/28/2023

NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023. Brad Gray, president and chief executive officer, is scheduled to present on Tuesday, March 7, 2023, at 1:30pm ET.
  • 02/23/2023

NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and fiscal year 2022 operating results after the close of the market on Tuesday, February 28, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
  • 02/14/2023

NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference

  • SEATTLE--( BUSINESS WIRE )--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company's management is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference.
  • 12/22/2022

NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.
  • 11/10/2022

NanoString Technologies (NSTG) Reports Q3 Loss, Misses Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -71.74% and 16.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 11/07/2022

NanoString to Release Third Quarter 2022 Operating Results and Host Conference Call on Monday, November 7, 2022

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report third quarter 2022 operating results after the close of the market on Monday, November 7, 2022.
  • 10/12/2022

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming financial conferences. Morgan Stanley 20th Annual Global Healthcare Conference Monday, September 12th Brad Gray, NanoString's chief executive officer, will participate in a fireside discussion at 1:05pm ET. 2022 Baird Global Healthcare Conference Tu
  • 09/07/2022

NanoString Technologies, Inc.'s (NSTG) CEO Brad Gray on Q2 2022 Earnings Call Transcript

  • NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Doug Farrell - Vice President, Investor Relations Brad Gray - President and Chief Executive Officer Tom Bailey - Chief Financial Officer Conference Call Participants Alex Vukasin - Canaccord Genuity Dan Brennan - Cowen Edmund Debler - Morgan Stanley Dan Arias - Stifel Operator Hello and welcome to the NanoString Second Quarter Operating Results. My name is Katie, and I'll be coordinating your call today.
  • 08/06/2022

NanoString Technologies (NSTG) Reports Q2 Loss, Lags Revenue Estimates

  • NanoString (NSTG) delivered earnings and revenue surprises of -37.10% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 08/04/2022

NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. 42nd Annual Canaccord Global Growth Conference Wednesday, August 10th Brad Gray, NanoString's chief executive officer, will participate in a spatial biology panel titled, “The New Frontier of Life Sciences: Spatial Omics is T
  • 08/04/2022

Wall Street Analysts See a 172% Upside in NanoString (NSTG): Can the Stock Really Move This High?

  • The consensus price target hints at a 171.7% upside potential for NanoString (NSTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
  • 07/21/2022

NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022

  • SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report second quarter 2022 operating results after the close of the market on Thursday, August 4, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update. Investors and other interested parties should register for the conference cal
  • 07/11/2022

NanoString to Webcast Presentation from the UBS 2022 Global Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 2022 UBS Global Healthcare Conference. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, May 25, 2022, at 9:15 am ET. Interested parties can access the live webcast with accompanying slides from the investor section of
  • 05/18/2022

NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2022 Earnings Call Transcript

  • NanoString Technologies, Inc. Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Doug Farrell - VP of IR & Corporate Communications Brad Gray - CEO, President & Director Tom Bailey - CFO Conference Call Participants Daniel Brennan - Cowen Dan Arias - Stifel Julia Qin - JPMorgan Kyle Mikson - Canaccord Genuity Catherine Schulte - Robert W. Baird Tejas Savant - Morgan Stanley Operator Hello.
  • 05/10/2022

NanoString to Release First Quarter 2022 Operating Results and Host Conference Call on Tuesday, May 10, 2022

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2022 operating results after the close of the market on Tuesday, May 10, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update. Investors and other interested parties should register for the conference call in
  • 04/27/2022

NanoString stock plunges after revenue warning, but analyst says selloff appears 'way overdone'

  • Shares of NanoString Technologies Inc. ntsg plunged 32.8% toward a two-year low in morning trading Wednesday, enough to make them the biggest losers trading on major U.S. exchanges, after the provider of life science discovery tools warned about a revenue miss, citing execution missteps. The company said late Tuesday that it now expects first-quarter product and service revenue of $31 million, below the previously provided guidance range of $34 million to $38 million.
  • 04/13/2022

Does NanoString (NSTG) Have the Potential to Rally 117% as Wall Street Analysts Expect?

  • The mean of analysts' price targets for NanoString (NSTG) points to an 116.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
  • 04/06/2022

NanoString Technologies' (NSTG) CEO Brad Gray on Q4 2021 Earnings Call Transcript

  • NanoString Technologies' (NSTG) CEO Brad Gray on Q4 2021 Earnings Call Transcript
  • 03/01/2022

NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at 11th Annual SVB Leerink Healthcare Conference.
  • 02/09/2022

NanoString Expects Q4 Product And Service Revenue Growth Of 18%

  • NanoString Technologies Inc (NASDAQ: NSTG) expects Q4 FY21 product and service revenue of approximately $42 million, +18% Y/Y and at the upper end of the company's guidance of $38 million - $42 million. For FY21, the company expects product and service revenue to be approximately $144 million, +29% YY and at the upper end of the company's prior guidance of $140 million - $144 million.
  • 01/10/2022

NanoString Technologies' Q3 Fall Short Street View; Cuts FY21 Guidance

  • NanoString Technologies Inc (NASDAQ: NSTG) reported Q3 sales of $37.15 million, +17% Y/Y, mainly driven by instrument sales, demand for consumables, and services. Q3 sales fell slightly short of analysts' consensus estimate of $37.79 million.
  • 11/10/2021

NanoString to Webcast Presentation from the Stifel 2021 Virtual Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at the 2021 Stifel Virtual Healthcare Conference.
  • 11/10/2021

NanoString Technologies' (NSTG) CEO Brad Gray on Q3 2021 Results - Earnings Call Transcript

  • NanoString Technologies' (NSTG) CEO Brad Gray on Q3 2021 Results - Earnings Call Transcript
  • 11/09/2021

NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments

  • SEATTLE--(BUSINESS WIRE)--NanoString announces the launch of the nCounter® ADC Development Panel.
  • 10/12/2021

NanoString to Release Third Quarter 2021 Operating Results and Host Conference Call on Tuesday, November 9, 2021

  • SEATTLE--(BUSINESS WIRE)--NanoString to host third quarter 2021 operating results webcast on Tuesday, November 9th, 2021.
  • 10/06/2021

NanoString to Webcast Presentation from the 19th Annual Morgan Stanley Global Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to present at Morgan Stanley Global Healthcare Conference.
  • 09/01/2021

NanoString's GeoMx Digital Spatial Profiling Platform Reveals Insights Into the Immune Landscape of Cancer in Publication in the Journal Cell

  • SEATTLE--(BUSINESS WIRE)--NanoString announced a peer-reviewed publication using the GeoMx® Digital Spatial Profiler (DSP), published in the journal Cell.
  • 08/31/2021

NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q2 2021 Results - Earnings Call Transcript

  • NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q2 2021 Results - Earnings Call Transcript
  • 08/04/2021

NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021

  • SEATTLE--(BUSINESS WIRE)--NanoString to report second quarter 2021 operating results and host conference call on Wednesday, August 4th.
  • 07/08/2021

NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy

  • SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® Stem Cell Characterization Panel for the analysis and optimization of stem cell lines used in the development of potential novel therapeutics. Recent breakthroughs in stem cell therapy, regenerative medicine, and CRISPR engineering have advanced the development of promising new treatments for debili
  • 06/22/2021

NanoString: Compelling Upside For This Spatial Biology Instrument Developer

  • NanoString Technologies, Inc. is a genomics/proteomics-focused developer of advanced instruments and consumables for scientific and clinical research. NanoString's products consist of two commercially available product platforms, the nCounter Analysis System (launched in 2008) and the GeoMx Digital Spatial Profiler System ("DSP" launched in 2019).
  • 06/17/2021

NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer

  • SEATTLE & SAN FRANCISCO--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and the Parker Institute for Cancer Immunotherapy (PICI) announced today that they are collaborating on an expansive molecular characterization project for cellular therapies. The collaboration will define the characteristics that make a cell therapy effective, providing a standardized approach to developing CAR-T regimens tha
  • 06/15/2021

NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the Jefferies Virtual Healthcare conference.
  • 05/27/2021

Down More Than 20%, Is This Cathie Wood Biotech A Buy?

  • 10x Genomics stock has fallen, despite announcing strong first-quarter numbers.
  • 05/20/2021

NanoString to Webcast Presentation from the UBS Global Healthcare Conference

  • SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the UBS Global Healthcare Conference.